Literature DB >> 7857294

A plant steroid, diosgenin, a new megakaryocytic differentiation inducer of HEL cells.

J L Beneytout1, C Nappez, M J Leboutet, G Malinvaud.   

Abstract

We investigated the effect of plant steroids 5 alpha-spirosten-3 beta-ol (diosgenin), 5 alpha-spirostan-3 beta-ol (tigogenin) and 5 alpha-spirostan-3 beta-ol-12-one (hecogenin) on the human erythroleukemia cell line (HEL TIB 180) and found that diosgenin addition to HEL cell cultures induces morphological and biochemical changes characteristic for megakaryocyte cells. Diosgenin-treated cells exhibit, at the ultrastructural level, increases in size in cytoplasmic and nuclear complexity. At the biochemical level, we demonstrated that diosgenin-treated HEL cells increased glycoprotein Ib (GpIb) expression as previously described in the megakaryocytic differentiation of HEL cells induced by nanomolar dose phorbol myristate acetate treatment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7857294     DOI: 10.1006/bbrc.1995.1201

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  The role of growth differentiation factor 15 in the pathogenesis of primary myelofibrosis.

Authors:  Tatsuki Uchiyama; Hiroshi Kawabata; Yasuo Miura; Satoshi Yoshioka; Masaki Iwasa; Hisayuki Yao; Soichiro Sakamoto; Masakazu Fujimoto; Hironori Haga; Norimitsu Kadowaki; Taira Maekawa; Akifumi Takaori-Kondo
Journal:  Cancer Med       Date:  2015-08-15       Impact factor: 4.452

2.  Involvement of autophagy in diosgenin‑induced megakaryocyte differentiation in human erythroleukemia cells.

Authors:  Bertrand Liagre; David Yannick Leger; Dima Diab; Aline Pinon; Catherine Ouk; Rouba Hage-Sleiman; Mona Diab-Assaf
Journal:  Mol Med Rep       Date:  2021-08-30       Impact factor: 2.952

3.  Sonic Hedgehog activation is implicated in diosgenin-induced megakaryocytic differentiation of human erythroleukemia cells.

Authors:  Lamia Ghezali; Bertrand Liagre; Youness Limami; Jean-Louis Beneytout; David Yannick Leger
Journal:  PLoS One       Date:  2014-04-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.